Literature DB >> 25765544

The DEK oncoprotein and its emerging roles in gene regulation.

C Sandén1, U Gullberg1.   

Abstract

The DEK oncogene is highly expressed in cells from most human tissues and overexpressed in a large and growing number of cancers. It also fuses with the NUP214 gene to form the DEK-NUP214 fusion gene in a subset of acute myeloid leukemia. Originally characterized as a member of this translocation, DEK has since been implicated in epigenetic and transcriptional regulation, but its role in these processes is still elusive and intriguingly complex. Similarly multifaceted is its contribution to cellular transformation, affecting multiple cellular processes such as self-renewal, proliferation, differentiation, senescence and apoptosis. Recently, the roles of the DEK and DEK-NUP214 proteins have been elucidated by global analysis of DNA binding and gene expression, as well as multiple functional studies. This review outlines recent advances in the understanding of the basic functions of the DEK protein and its role in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25765544     DOI: 10.1038/leu.2015.72

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  74 in total

1.  SAP - a putative DNA-binding motif involved in chromosomal organization.

Authors:  L Aravind; E V Koonin
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  Transcriptional activation by AP-2alpha is modulated by the oncogene DEK.

Authors:  Mónica Campillos; Miguel Angel García; Fernando Valdivieso; Jesús Vázquez
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

3.  Intron removal requires proofreading of U2AF/3' splice site recognition by DEK.

Authors:  Luis Miguel Mendes Soares; Katia Zanier; Cameron Mackereth; Michael Sattler; Juan Valcárcel
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

Review 4.  Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene.

Authors:  M von Lindern; M Fornerod; N Soekarman; S van Baal; M Jaegle; A Hagemeijer; D Bootsma; G Grosveld
Journal:  Baillieres Clin Haematol       Date:  1992-10

5.  Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene.

Authors:  Morgan Sammons; Shan Shan Wan; Nancy L Vogel; Edwin J Mientjes; Gerard Grosveld; Brian P Ashburner
Journal:  J Biol Chem       Date:  2006-07-07       Impact factor: 5.157

6.  Translocation (6;9)(p23;q34) in acute nonlymphocytic leukemia.

Authors:  S Schwartz; R Jiji; S Kerman; J Meekins; M M Cohen
Journal:  Cancer Genet Cytogenet       Date:  1983-10

7.  Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Authors:  N Kondoh; T Wakatsuki; A Ryo; A Hada; T Aihara; S Horiuchi; N Goseki; O Matsubara; K Takenaka; M Shichita; K Tanaka; M Shuda; M Yamamoto
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

8.  Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements.

Authors:  M Fornerod; J Boer; S van Baal; M Jaeglé; M von Lindern; K G Murti; D Davis; J Bonten; A Buijs; G Grosveld
Journal:  Oncogene       Date:  1995-05-04       Impact factor: 9.867

9.  DEK proto-oncogene expression interferes with the normal epithelial differentiation program.

Authors:  Trisha M Wise-Draper; Richard J Morreale; Teresa A Morris; Rachael A Mintz-Cole; Elizabeth E Hoskins; Scott J Balsitis; Nader Husseinzadeh; David P Witte; Kathryn A Wikenheiser-Brokamp; Paul F Lambert; Susanne I Wells
Journal:  Am J Pathol       Date:  2008-11-26       Impact factor: 4.307

Review 10.  Concise review: role of DEK in stem/progenitor cell biology.

Authors:  Hal E Broxmeyer; Nirit Mor-Vaknin; Ferdinand Kappes; Maureen Legendre; Anjan K Saha; Xuan Ou; Heather O'Leary; Maegan Capitano; Scott Cooper; David M Markovitz
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

View more
  16 in total

1.  MicroRNA-1292-5p inhibits cell growth, migration and invasion of gastric carcinoma by targeting DEK.

Authors:  Wentao Hui; Xiaobin Ma; Ying Zan; Lingqin Song; Shuqun Zhang; Lei Dong
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

2.  Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins.

Authors:  Jennifer A Bohn; Jamie L Van Etten; Trista L Schagat; Brittany M Bowman; Richard C McEachin; Peter L Freddolino; Aaron C Goldstrohm
Journal:  Nucleic Acids Res       Date:  2018-01-09       Impact factor: 16.971

Review 3.  A role for intracellular and extracellular DEK in regulating hematopoiesis.

Authors:  Maegan L Capitano; Hal E Broxmeyer
Journal:  Curr Opin Hematol       Date:  2017-07       Impact factor: 3.284

4.  Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells.

Authors:  Yao-Shun Yang; Xi-Zheng Jia; Qian-Yun Lu; Sun-Li Cai; Xue-Ting Huang; Shu-Hua Yang; Chris Wood; Yue-Hong Wang; Jiao-Jiao Zhou; Yi-Ding Chen; Jin-Shu Yang; Wei-Jun Yang
Journal:  Oncogene       Date:  2022-03-29       Impact factor: 9.867

5.  Potential of DEK proto-oncogene as a prognostic biomarker for colorectal cancer: An evidence-based review.

Authors:  Muhammad Habiburrahman; Muhammad Prasetio Wardoyo; Stefanus Sutopo; Nur Rahadiani
Journal:  Mol Clin Oncol       Date:  2022-05-26

6.  Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies.

Authors:  Daniel L Miller; Doreen N Palsgrove; Anu Rijal; Vivan Hathuc; Rebecca Chernock; Jeffrey Gagan; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2022-02-26

7.  The DEK Oncoprotein Is a Critical Component of the EKLF/KLF1 Enhancer in Erythroid Cells.

Authors:  Felix Lohmann; Mohan Dangeti; Shefali Soni; Xiaoyong Chen; Antanas Planutis; Margaret H Baron; Kyunghee Choi; James J Bieker
Journal:  Mol Cell Biol       Date:  2015-08-24       Impact factor: 4.272

Review 8.  The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance.

Authors:  Jelani C Zarif; Cindy K Miranti
Journal:  Cell Signal       Date:  2016-01-29       Impact factor: 4.315

9.  DEK domain-containing proteins control flowering time in Arabidopsis.

Authors:  Wei Zong; Bo Zhao; Yanpeng Xi; Yogendra Bordiya; Hyungwon Mun; Nicholas A Cerda; Dong-Hwan Kim; Sibum Sung
Journal:  New Phytol       Date:  2021-05-02       Impact factor: 10.323

Review 10.  The diverse roles of SPOP in prostate cancer and kidney cancer.

Authors:  Zhiwei Wang; Yizuo Song; Miaomiao Ye; Xiaoming Dai; Xueqiong Zhu; Wenyi Wei
Journal:  Nat Rev Urol       Date:  2020-04-30       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.